These results suggest that high SIX4 expression in patients with colon cancer likely results in elevated STING expression, enhanced STING activation, inflammatory response, and increased infiltration of CD8+ lymphocytes compared with low SIX4 expression. This evidence concerns the gene STING1 and malignant colon neoplasm.